Literature DB >> 6090001

The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases.

T M Ulbright, P J Loehrer, L M Roth, L H Einhorn, S D Williams, S A Clark.   

Abstract

Eleven male patients had germ cell tumors of the testis (7), mediastinum (3), or retroperitoneum (1) in which non-germ cell malignancies developed. Such malignant non-germ cell elements were present in the primary excisions of five patients and were subsequently found in additional resected tissue in 10 of 11 patients. In the patients who had multiple pathology specimens examined, a progression from atypia to predominant non-germ cell malignancy was often found. The authors believe these malignant elements arose within teratomatous foci, since eight of nine cases had teratoma in the primary tumor, and teratoma was found in subsequently resected tissue in one additional case. Cisplatin therapy frequently "unmasked" the non-germ cell malignant elements by destroying the more chemosensitive germ cell cancers. The prognosis was worst for five patients who developed progressive embryonal rhabdomyosarcoma: two of these patients died of local spread of tumor, whereas a third died of metastatic sarcoma. Only one patient, who had total surgical excision of rhabdomyosarcoma, survived. Other forms of sarcoma that developed within germ cell tumors did not appear to adversely affect the prognosis beyond that of teratoma. It is currently recommended, when feasible, that patients with teratoma and sarcoma undergo total surgical excision. Further treatment with cisplatin regimens, after eradication of the germ cell component, has not been helpful. The role of other forms of chemotherapy remains speculative.

Entities:  

Mesh:

Year:  1984        PMID: 6090001     DOI: 10.1002/1097-0142(19841101)54:9<1824::aid-cncr2820540910>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  36 in total

1.  Testicular germ cell tumors with sarcomatous components: an analysis of 33 cases.

Authors:  Charles C Guo; Metin Punar; Alejandro Luiña Contreras; Shi-Ming Tu; Louis Pisters; Pheroze Tamboli; Bogdan Czerniak
Journal:  Am J Surg Pathol       Date:  2009-08       Impact factor: 6.394

2.  Low-grade sarcoma in classical seminoma - the first case reported.

Authors:  Fredrik Petersson; Michal Michal; Petr Grossmann; Marcello Franco; Michal Zámecník; Ondrej Hes
Journal:  Int J Clin Exp Pathol       Date:  2009-11-01

Review 3.  Teratoma with somatic-type malignant components of the testis. A review and an update.

Authors:  Gregor Mikuz; Maurizio Colecchia
Journal:  Virchows Arch       Date:  2012-05-24       Impact factor: 4.064

Review 4.  [Mediastinal germ cell tumors].

Authors:  F Bremmer; P Ströbel
Journal:  Pathologe       Date:  2016-09       Impact factor: 1.011

5.  Growing mediastinal metastatic tumour in a patient with burned out testicular cancer.

Authors:  K Suzuki; T Yoshida; M Inoue; I Yoshida; K Kurokawa; T Suzuki; K Imai; H Yamanaka
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

6.  [Primitive neuroectodermal tumor of the testis. Molecular analysis and discussion of genesis].

Authors:  S Brandt; B Lohe; A Vogetseder; T Rüdiger; H Moch; P Bode
Journal:  Pathologe       Date:  2013-02       Impact factor: 1.011

7.  Remission of recurrent mature teratoma with interferon therapy.

Authors:  D Ornadel; A Wilson; C Trask; J Ledermann
Journal:  J R Soc Med       Date:  1995-09       Impact factor: 5.344

Review 8.  [Non-seminomatous germ cell tumours].

Authors:  F Bremmer; C L Behnes; S Schweyer
Journal:  Pathologe       Date:  2014-05       Impact factor: 1.011

9.  Teratoma with malignant transformation in the anterior mediastinum: a case report.

Authors:  J I Jung; S H Park; J G Park; S H Lee; K Y Lee; S T Hahn
Journal:  Korean J Radiol       Date:  2000 Jul-Sep       Impact factor: 3.500

10.  Embryonal rhabdomyosarcoma arising from a mediastinal teratoma: an unusual case report.

Authors:  Young-Joon Ryu; Su Hyun Yoo; Min Jung Jung; Sejin Jang; Kyung-Ja Cho
Journal:  J Korean Med Sci       Date:  2013-03-04       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.